1. Advances in epigenetic glioblastoma therapy
   Dong Hoon Lee et al, 2017, Oncotarget CrossRef
2. Discovery of Selective SIRT2 Inhibitors as Therapeutic Agents in B-Cell Lymphoma and Other Malignancies
   Sarwat Chowdhury et al, 2020, Molecules CrossRef
3. Fisetin disrupts mitochondrial homeostasis via superoxide dismutase 2 acetylation in pancreatic adenocarcinoma
   Yimin Ding et al, 2024, Phytotherapy Research CrossRef
4. Label-free quantitative proteomics unravels the importance of RNA processing in glioma malignancy
   Baibin Bi et al, 2017, Neuroscience CrossRef
5. Infection Reveals a Modification of SIRT2 Critical for Chromatin Association
   Jorge M. Pereira et al, 2018, Cell Reports CrossRef
6. The Clinical Significance of SIRT2 in Malignancies: A Tumor Suppressor or an Oncogene?
   Lin Zhang et al, 2020, Frontiers in Oncology CrossRef
7. Role of sirtuins in epigenetic regulation and aging control
   E. M. Samoilova et al, 2024, Vavilov Journal of Genetics and Breeding CrossRef
8. SIRT1 in Neurodevelopment and Brain Senescence
   A. Zara Herskovits et al, 2014, Neuron CrossRef
9. Differential expression of sirtuin family members in the developing, adult, and aged rat brain
   Elena Sidorova-Darmos et al, 2014, Frontiers in Aging Neuroscience CrossRef
10. SIRT2: Controversy and multiple roles in disease and physiology
    Yan Wang et al, 2019, Ageing Research Reviews CrossRef
11. Active nuclear import of the deacetylase Sirtuin-2 is controlled by its C-terminus and importins
    Matthew J. G. Eldridge et al, 2020, Scientific Reports CrossRef